Electrical treatment for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a special electrical treatment (irreversible electroporation) for liver tumors. It aims to destroy cancer cells safely while preserving healthy liver tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your liver function must be good (Child-Pugh score up to A6).
- You should be up and about and able to care for yourself, though you may not be able to do heavy physical work (ECOG score 0-2).
- You should not have other health conditions that make you very frail (Rockwood Frailty Score 3 or less).
- Your liver and kidney blood test results must be within certain limits (bilirubin and creatinine).
- You can have up to 3 liver tumors, each smaller than 3 centimeters, and no cancer spread outside the liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called irreversible electroporation (IRE), which uses electrical pulses to destroy liver tumors that have spread from colorectal cancer. It aims to treat liver tumors that are too small or in tricky spots for surgery, and you may also have surgery to remove some tumors if needed.
This trial tests a combination treatment for advanced liver cancer that cannot be removed with surgery. It combines a procedure (irreversible electroporation) that uses electrical pulses to destroy cancer cells, with targeted therapy (lenvatinib) and immunotherapy (sintilimab) to help your immune system fight the cancer.
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
This study tests a computer-guided microwave ablation procedure to destroy liver tumors. If you have early-stage liver cancer with up to 5 tumors, and one is 2-5 cm in size, you may be a candidate.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.